Author

Yuki Taki

Chiba UniversityORCID 0009-0003-6982-9167Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Tomoaki TanakaiD· 2 shared Akitoshi Nakayama· 1 shared Ali R. NasiriiD· 1 shared Birgit KnebeliD· 1 shared Daniel F. VatneriD· 1 shared Dean YimlamaiiD· 1 shared Gerald I. ShulmaniD· 1 shared Ikki SakumaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Tomoaki TanakaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintJul 3, 2026

Organ-resolved endothelial regulatory programs link aging and metabolic overload to vascular immune remodeling

Masataka Yokoyama, Akitoshi Nakayama, Yuki Taki…·Tomoaki Tanaka

This study identifies organ-specific endothelial regulatory programs in aging and metabolic overload, revealing how vascular immune remodeling is coupled to local inflammatory restraint.

DOI 10.64898/2026.07.02.736039

humanscRNA-seq

𝕏 PostBluesky

PathologyProceedings of the National Academy of SciencesPeer-reviewedMay 1, 2025

✦ In-depth digest

Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis

Ikki Sakuma, Rafael Calais Gaspar, Ali R. Nasiri…·Gerald I. Shulman

Cholesterol accumulation in hepatic lipid droplets drives inflammation and fibrosis in mouse and human MASH and is reversed by inhibiting cholesterol synthesis or knocking down Coasy or Hsd17b13.

46 citationstop 1%

mousehuman

𝕏 PostBluesky